Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.43 |
| ▸ | TNKS | O95271 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.36 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | GABRP | O00591 | 1/20 | 0.33 |
| ▸ | GABRD | O14764 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31195961 | 1.00 | AHR (0.43) | AHRTNKSKDM4EKMT2AMEN1 | |
| SCHEMBL25608187 | 0.91 | NPC1 (0.40) | AHRTNKSKDM4EKMT2AMEN1 | |
| SCHEMBL22506183 | 0.90 | AHR (0.48) | AHRTNKSKDM4EKMT2ARAB9A | |
| SCHEMBL18212070 | 0.90 | NPC1 (0.41) | AHRTNKSKDM4EKMT2AMEN1 | |
| SCHEMBL22506181 | 0.89 | AHR (0.47) | AHRTNKSKDM4EKMT2ARAB9A | |
| SCHEMBL21984324 | 0.89 | AHR (0.39) | AHRTNKSKDM4EKMT2AMEN1 | |
| SCHEMBL18212124 | 0.89 | PLA2G2A (0.42) | AHRTNKSKDM4EKMT2AMEN1 | |
| SCHEMBL17083563 | 0.88 | MAPT (0.40) | AHRTNKSKDM4EKMT2AMEN1 | |
| SCHEMBL22506442 | 0.88 | AHR (0.50) | AHRTNKSKDM4EKMT2ARAB9A | |
| SCHEMBL17285617 | 0.87 | HPGD (0.39) | AHRTNKSKDM4EKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11917909-B2 | Organic compound and organic electroluminescence device using the same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
| US-11917909-B2 | Organic compound and organic electroluminescence device using the same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2024-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11917909-B2 | Organic compound and organic electroluminescence device using the same | SLC25A21, PIEZO1, SLCO4C1 | AHR 1509/4885TNKS 3412/4885KDM4E 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.